Table 4 Hysteroscopy using normal saline and subsequent positive peritoneal cytology
From: The role of hysteroscopy in diagnosis and management of endometrial cancer
Authors | No. of patients | Positive peritoneal cytology | Intrauterine pressure (mmHg) | Duration of follow-up (months) | Recurrence |
|---|---|---|---|---|---|
Arikan et al. [2] | 24 | 20 (83%) | 100–150 | NA | NA |
Gu et al. [4] | 23 | 3 (13.0%) | NA | 16–83 | NA |
Ben-Arie et al. [5] | 100 | 1 (1%) | 100 | 25 | NA |
Bradley et al. [6] | 52 | 4 (7.7%) | NA | NA | NA |
Selvaggi et al. [16] | 39 | 9 (23%) | 150 | NA | NA |
Takac et al. [17] | 24 | 3 (12.5%) | NA | NA | |
Kudela et al. [18] | 134 | 4 (5.3%) | NA | 60 | NA |
Lo et al. [26] | 50 | 7 (14%) | NA | 12–34 | None |
Nagele et al. [28] | 30 | 7 (23%) | NA | NA | NA |
Zerbe et al. [29] | 64 | 11 (17.2%) | NA | NA | NA |
Leveque et al. [30] | 28 | 7 (37%) | NA | 25 | None |
Solima et al. [31] | 40 | 2 (5%) | 40 | NA | NA |
Obermair et al. [32] | 113 | 10 (8.8%) | NA | NA | NA |
Biewenga et al. [33] | 50 | 0 (0%) | NA | 60 | NA |
Duan et al. [34] | 121 | 61(51.2%) | NA | NA | NA |
Cuesta et al. [35] | 38 | 8 (21%) | NA | 34a | None |